SEOPRO, the AI-powered Project & Portfolio Management platform from Seosaph Infotech, made a major splash at Eminence Business Media’s 9th Annual Pharma Project & Portfolio Management Conference 2026. Senior leaders across pharmaceutical R&D, portfolio governance, regulatory affairs, and enterprise PMOs gave the platform enthusiastic validation.

 

Positioned as the first AI-enabled PPM platform built by a pharma insider to tackle the unique complexities of regulated pharmaceutical environments, SEOPRO grabbed attention for transforming fragmented project data into structured, decision-ready intelligence.

 

During live demonstrations, industry leaders highlighted SEOPRO’s ability to spot portfolio risk, execution bottlenecks, and decision delays early—before they escalate into costly program disruptions.

 

Delegates from top pharma companies requested personalized follow-up demos, signaling SEOPRO’s relevance for enterprise-scale portfolio challenges.

 

Harshita Shah from Zydus Lifesciences said: "In pharma project management, complexity is a given - multiple teams, tight timelines, and constant dependencies. What matters most is clarity and trust. What I really appreciate about SEOPRO is that it doesn’t try to replace human judgment but give it a boost. It gives you the right visibility, the right signals, and the right insights - and lets the project manager stay in control.”

 

She emphasized SEOPRO’s ability to quantify risk with measurable accuracy, a feature often missing in traditional tools.

 

Delegates also noted SEOPRO’s unique capabilities in: early risk identification across portfolios before delays surface; evidence-based portfolio reviews replacing subjective status reporting; traceable, regulator-ready documentation embedded in workflows.

 

Unlike generic SaaS platforms retrofitted for healthcare, SEOPRO was designed from the ground up by professionals with deep pharma R&D and regulatory experience. In environments where delays are costly, data integrity is critical, and accountability is non-negotiable, the platform combines AI-driven risk intelligence with human-led decision control.

 

Reflecting on the reception at EBMPPPM 2026, Ashwini Shrivastava, Product Lead, SEOPRO, said: "The response has been overwhelming. Being recognized by industry leaders validates our belief that pharma portfolio management requires a fundamentally different, more intelligent approach—one that strengthens decision-making rather than automating it blindly.”

 

SEOPRO’s strong debut at EBMPPPM 2026 underscores its growing role with global pharma organizations seeking smarter, faster, and more defensible portfolio decisions.

 

Nagarajan Selvaraj, CEO of Seosaph Infotech, remarked: "Pharma project and portfolio management cannot rely on fragmented tools and retrospective reporting anymore. The industry needs predictive visibility, accountable decision intelligence, and platforms built specifically for regulated environments. SEOPRO was created with that belief. 

 

"It is not just an automation tool — it is a governance engine designed to strengthen human judgment with evidence. The response at EBMPPPM 2026 reinforces that pharma leaders are ready to move from reactive execution to intelligent portfolio control.”